News
Hims & Hers Health first-quarter revenue more than doubled as subscribers rose 38%, while its second-quarter sales outlook ...
AbbVie snagged yet another spot among April’s highest TV ad spenders, as its Vraylar jumped two spots to eighth place with a ...
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...
Hims & Hers Health appoints former Amazon executive Nader Kabbani as its chief operating officer. The telehealth-consultation platform on Monday said Kabbani will oversee operations as the company ...
PRESS RELEASE FROM THE MINISTRY OF HEALTH AND HUMAN SERVICES Cockburn Town, Turks and Caicos Islands, 2nd May 2025: In ...
Lotte Bjerre Knudsen lives comfortably in this pleasant, but not showy, £900,000 apartment in central Copenhagen with her ...
BRITS could soon be able to get Ozempic-style fat jabs from high street pharmacies, according to reports. Drugs like Wegovy ...
Todd Engels, 62, from Maryland, started taking Ozempic after he saw glowing headlines and slick ads praising it as a 'miracle ...
FAT jabs like Ozempic are set to get the seal of approval from the World Health Organisation (WHO). This would back the use ...
Healthify is banking on the rise of GLP-1 weight-loss drugs in India, integrating them with lifestyle coaching. The firm ...
Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...
A latest study has shown promising results in people suffering from metabolic dysfunction-associated steatohepatitis (MASH), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results